Kereiakes, D. J., Lincoff, A. M., Simoons, M. L., deBoer, M. J., Tcheng, J. E., Vahanian, A., … Califf, R. M. (1998). Abciximab benefit in coronary intervention has no gender bias: Results of EPIC, EPILOG and CAPTURE trials. AMERICAN JOURNAL OF CARDIOLOGY, 82(7A), 95S-95S.

Kereiakes, D. J., A. M. Lincoff, M. L. Simoons, M. J. deBoer, J. E. Tcheng, A. Vahanian, K. M. Anderson, C. F. Cabot, and R. M. Califf. “Abciximab benefit in coronary intervention has no gender bias: Results of EPIC, EPILOG and CAPTURE trials.” AMERICAN JOURNAL OF CARDIOLOGY 82, no. 7A (October 1, 1998): 95S-95S.

Kereiakes DJ, Lincoff AM, Simoons ML, deBoer MJ, Tcheng JE, Vahanian A, et al. Abciximab benefit in coronary intervention has no gender bias: Results of EPIC, EPILOG and CAPTURE trials. AMERICAN JOURNAL OF CARDIOLOGY. 1998 Oct 1;82(7A):95S-95S.

Kereiakes, D. J., et al. “Abciximab benefit in coronary intervention has no gender bias: Results of EPIC, EPILOG and CAPTURE trials.” AMERICAN JOURNAL OF CARDIOLOGY, vol. 82, no. 7A, EXCERPTA MEDICA INC, Oct. 1998, pp. 95S-95S.

Kereiakes DJ, Lincoff AM, Simoons ML, deBoer MJ, Tcheng JE, Vahanian A, Anderson KM, Cabot CF, Califf RM. Abciximab benefit in coronary intervention has no gender bias: Results of EPIC, EPILOG and CAPTURE trials. AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 1998 Oct 1;82(7A):95S-95S.